Impact of COVID-19 outbreak on physical activity of patients with implantable cardioverter defibrillators
Physical activity (PA) is a cornerstone of prevention to decrease mortality in patients with chronic cardiovascular disease including heart failure [1,2]. Implantable cardiac devices offer the opportunity to monitor PA and data derived from implantable devices have been associated with short- and long-term outcomes [3,4]. During the SARS-CoV2 pandemic, restrictions to outdoor activity were imposed by national authorities. In Italy, after the first case of Coronavirus disease –2019 (COVID-19) on February 21st, the so called “lockdown” act was passed on March 8th 2020 [5].
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Giovanni Malanchini, Maurizio Malacrida, Paola Ferrari, Cristina Leidi, Gabriele Ferrari, Marco Racheli, Michele Senni, Paolo De Filippo Tags: Research Letter Source Type: research
More News: Cardiology | Cardiovascular | Coronavirus | COVID-19 | Heart | Heart Failure | Italy Health | Outbreaks | Pandemics | SARS